vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and TKO Group Holdings (TKO). Click either name above to swap in a different company.

TKO Group Holdings is the larger business by last-quarter revenue ($1.0B vs $749.2M, roughly 1.4× CLOVER HEALTH INVESTMENTS, CORP.). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — 3.6% vs -0.2%, a 3.9% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 61.6%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 28.4%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

TKO Group Holdings, Inc. (TKO) is an American sports and sports entertainment company. Established on September 12, 2023, the public company was formed by a merger between Endeavor subsidiary Zuffa—the parent company of the Ultimate Fighting Championship (UFC), a mixed martial arts promotion—and the professional wrestling promotion World Wrestling Entertainment (WWE).

CLOV vs TKO — Head-to-Head

Bigger by revenue
TKO
TKO
1.4× larger
TKO
$1.0B
$749.2M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+0.4% gap
CLOV
62.0%
61.6%
TKO
Higher net margin
CLOV
CLOV
3.9% more per $
CLOV
3.6%
-0.2%
TKO
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
28.4%
TKO

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLOV
CLOV
TKO
TKO
Revenue
$749.2M
$1.0B
Net Profit
$27.3M
$-2.4M
Gross Margin
Operating Margin
3.6%
5.5%
Net Margin
3.6%
-0.2%
Revenue YoY
62.0%
61.6%
Net Profit YoY
-107.7%
EPS (diluted)
$0.05
$-0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
TKO
TKO
Q1 26
$749.2M
Q4 25
$487.7M
$1.0B
Q3 25
$496.6M
$1.1B
Q2 25
$477.6M
$1.3B
Q1 25
$462.3M
$1.3B
Q4 24
$337.0M
$642.2M
Q3 24
$331.0M
$681.3M
Q2 24
$356.3M
$851.2M
Net Profit
CLOV
CLOV
TKO
TKO
Q1 26
$27.3M
Q4 25
$-49.3M
$-2.4M
Q3 25
$-24.4M
$41.0M
Q2 25
$-10.6M
$98.4M
Q1 25
$-1.3M
$58.4M
Q4 24
$-22.1M
$31.0M
Q3 24
$-9.2M
$23.1M
Q2 24
$7.4M
$59.1M
Gross Margin
CLOV
CLOV
TKO
TKO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Operating Margin
CLOV
CLOV
TKO
TKO
Q1 26
3.6%
Q4 25
-10.1%
5.5%
Q3 25
-4.9%
15.4%
Q2 25
-2.2%
28.1%
Q1 25
-0.3%
18.7%
Q4 24
-6.4%
15.9%
Q3 24
-2.7%
20.0%
Q2 24
2.0%
30.0%
Net Margin
CLOV
CLOV
TKO
TKO
Q1 26
3.6%
Q4 25
-10.1%
-0.2%
Q3 25
-4.9%
3.7%
Q2 25
-2.2%
7.5%
Q1 25
-0.3%
4.6%
Q4 24
-6.6%
4.8%
Q3 24
-2.8%
3.4%
Q2 24
2.1%
6.9%
EPS (diluted)
CLOV
CLOV
TKO
TKO
Q1 26
$0.05
Q4 25
$-0.07
Q3 25
$0.47
Q2 25
$1.17
Q1 25
$0.69
Q4 24
$0.28
Q3 24
$0.28
Q2 24
$0.72

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
TKO
TKO
Cash + ST InvestmentsLiquidity on hand
$177.6M
$831.1M
Total DebtLower is stronger
$3.8B
Stockholders' EquityBook value
$339.4M
$3.7B
Total Assets
$697.7M
$15.5B
Debt / EquityLower = less leverage
1.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
TKO
TKO
Q1 26
$177.6M
Q4 25
$78.3M
$831.1M
Q3 25
$861.4M
Q2 25
$535.1M
Q1 25
$470.9M
Q4 24
$194.5M
$525.6M
Q3 24
$288.0M
$457.4M
Q2 24
$254.8M
$277.5M
Total Debt
CLOV
CLOV
TKO
TKO
Q1 26
Q4 25
$3.8B
Q3 25
$3.7B
Q2 25
$2.7B
Q1 25
$2.8B
Q4 24
$2.8B
Q3 24
$2.7B
Q2 24
$2.7B
Stockholders' Equity
CLOV
CLOV
TKO
TKO
Q1 26
$339.4M
Q4 25
$308.7M
$3.7B
Q3 25
$340.9M
$3.8B
Q2 25
$344.2M
$4.3B
Q1 25
$336.1M
$4.2B
Q4 24
$341.1M
$4.1B
Q3 24
$342.2M
$4.0B
Q2 24
$324.9M
$4.0B
Total Assets
CLOV
CLOV
TKO
TKO
Q1 26
$697.7M
Q4 25
$541.0M
$15.5B
Q3 25
$559.7M
$15.5B
Q2 25
$575.0M
$15.3B
Q1 25
$583.7M
$15.0B
Q4 24
$580.7M
$12.7B
Q3 24
$653.0M
$12.8B
Q2 24
$674.2M
$12.7B
Debt / Equity
CLOV
CLOV
TKO
TKO
Q1 26
Q4 25
1.01×
Q3 25
0.98×
Q2 25
0.64×
Q1 25
0.66×
Q4 24
0.67×
Q3 24
0.67×
Q2 24
0.68×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
TKO
TKO
Operating Cash FlowLast quarter
$309.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
TKO
TKO
Q1 26
Q4 25
$-66.9M
$309.9M
Q3 25
$12.1M
$416.8M
Q2 25
$5.4M
$396.2M
Q1 25
$-16.3M
$162.8M
Q4 24
$34.8M
$56.8M
Q3 24
$50.0M
$236.5M
Q2 24
$44.8M
$230.7M
Free Cash Flow
CLOV
CLOV
TKO
TKO
Q1 26
Q4 25
$-69.0M
Q3 25
$11.4M
Q2 25
$4.8M
Q1 25
$-16.5M
Q4 24
$33.3M
Q3 24
$49.6M
Q2 24
$44.4M
FCF Margin
CLOV
CLOV
TKO
TKO
Q1 26
Q4 25
-14.1%
Q3 25
2.3%
Q2 25
1.0%
Q1 25
-3.6%
Q4 24
9.9%
Q3 24
15.0%
Q2 24
12.5%
Capex Intensity
CLOV
CLOV
TKO
TKO
Q1 26
Q4 25
0.4%
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.0%
Q4 24
0.5%
Q3 24
0.1%
Q2 24
0.1%
Cash Conversion
CLOV
CLOV
TKO
TKO
Q1 26
Q4 25
Q3 25
10.16×
Q2 25
4.03×
Q1 25
2.79×
Q4 24
1.83×
Q3 24
10.22×
Q2 24
6.04×
3.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

TKO
TKO

World Wrestling Entertainment Segment$359.6M35%
IMG Segment$247.6M24%
Media Rights Production And Content$222.6M21%
Partnerships And Marketing$93.3M9%
Live Events And Hospitality$72.2M7%
Other$29.4M3%
Consumer Products Licensing And Other$13.2M1%

Related Comparisons